SIGKNOW BIOMEDICAL CO., LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Unlock our primary solution for your heart – EZYPRO® Continuous ECG Monitor,
and colorectal condition screening at home – JustWipe® FOBT Kit.
We work and care for health professionals' workflow, and strive to satisfy the clinical need, enhance the testin
and colorectal condition screening at home – JustWipe® FOBT Kit.
We work and care for health professionals' workflow, and strive to satisfy the clinical need, enhance the testin
The content above was translated by Ai
Founded Year
2014
Unified Business No.
54621478
Status
Active
Number of Employees
0
Total Paid-in
Capital
100,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Established in 2014, we are committed to improving the diagnostic experience of patients and healthcare professionals around the globe with innovative Digital Health ready solutions that enable precise diagnosis, early detection, and prevention.
Tomorrow is now — embodied with medical grade wearables, big data, AI-enabled algorithm, our 14-day continuous patch ECG technology, and Professional-reviewed ECG reports are supporting Cardiologists and Neurologists in Asia, and shifting the Arrhythmia Diagnosis paradigm in the Region
Tomorrow is now — embodied with medical grade wearables, big data, AI-enabled algorithm, our 14-day continuous patch ECG technology, and Professional-reviewed ECG reports are supporting Cardiologists and Neurologists in Asia, and shifting the Arrhythmia Diagnosis paradigm in the Region
The content above was translated by Ai
